News Search

Diagnosed with stage 3 bladder cancer, Jeffrey Pulver underwent chemo, surgery, and a neobladder at Columbia—just in time to walk his daughter down the aisle, cancer-free, on their family farm.

Researchers from Columbia’s HICCC presented key research and insights at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held May 31 – June 3 in Chicago, Illinois.

Michel Sadelain, a pioneer in CAR-T therapy, is a key figure in the Pershing Square Foundation's $5.25M ovarian cancer research initiative, aiming to advance treatments for this underfunded disease.

After a surprise cancer diagnosis at 53, Rose leaned on her family, found strength through faith, and learned to prioritize her own health—with compassionate care from her Columbia team.